Ema Toshinari, Neyatani Hiroshi, Yamamoto Saki, Iizuka Shuhei, Funai Kazuhito, Shiiya Norihiko
Department of Thoracic Surgery, Fujieda Municipal General Hospital, Fujieda City, Shizuoka, Japan.
First Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu City, Shizuoka, Japan.
AME Case Rep. 2018 Nov 7;2:46. doi: 10.21037/acr.2018.10.03. eCollection 2018.
A 76-year-old Japanese man underwent right upper lung lobectomy for lung cancer. He had a medical history of atrial fibrillation and myocardial infarction, and was treated with medications including apixaban (5 mg twice daily). His postoperative course was uneventful, and he left the hospital on the ninth day postoperatively. Apixaban was restarted on postoperative day (POD) 10. On POD18, he was evaluated as an outpatient. He complained of fatigue, and his hemoglobin level decreased from 13.5 to 8.5 mg/dL. Chest plain radiography showed massive fluid in the right thoracic cavity. His condition was thought to be a postoperative bleeding complication due to apixaban; thus, we stopped apixaban and performed red blood cell transfusion and thoracic drainage. Postoperative hemorrhage associated with apixaban use is rare.
一名76岁的日本男性因肺癌接受了右上肺叶切除术。他有房颤和心肌梗死病史,正在接受包括阿哌沙班(每日两次,每次5毫克)在内的药物治疗。他的术后过程平稳,术后第9天出院。术后第10天重新开始使用阿哌沙班。术后第18天,他作为门诊患者接受评估。他主诉疲劳,血红蛋白水平从13.5毫克/分升降至8.5毫克/分升。胸部X线平片显示右侧胸腔有大量积液。他的情况被认为是阿哌沙班引起的术后出血并发症;因此,我们停用了阿哌沙班,并进行了红细胞输血和胸腔引流。与使用阿哌沙班相关的术后出血很少见。